|

CEA CAR-T cells Clinical Trials

2 actively recruiting trials

No change since May 2026

Pipeline

Phase 1: 2

Top Sponsors

  • Weijia Fang, MD1
  • Chongqing Precision Biotech Co., Ltd1

Indications

  • Gastric Cancer2
  • Cancer2
  • Solid Cancers1
  • Cholangiocarcinoma1
  • Pancreas Cancer1

Other2 trials

A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors
Phase 1
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.